SCHEMBL1843777

SCHEMBL1843777

Nc1nc2nc[nH]c2c(=O)n1S

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNP P00491 1/20 0.49
▸ DPP4 P27487 1/20 0.46
▸ PDPK1 O15530 1/20 0.44
▸ GDA Q9Y2T3 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.42
▸ CDK2 P24941 3/20 0.42
▸ MAP3K5 Q99683 1/20 0.39
▸ PI4KA P42356 2/20 0.38
▸ PI4K2B Q8TCG2 2/20 0.38
▸ PI4K2A Q9BTU6 2/20 0.38
▸ PI4KB Q9UBF8 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ XDH P47989 1/20 0.38
▸ LRRK2 Q5S007 1/20 0.38
▸ ATAD2 Q6PL18 1/20 0.38
▸ HRH4 Q9H3N8 1/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ PIK3CD O00329 1/20 0.37
▸ ALPL P05186 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL41788 0.81 PNP (0.50) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL27975255 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL8886040 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL852108 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL2983851 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL2051365 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL20579 0.79 DPP4 (0.50) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL20867 0.79 ATAD2 (0.53) PNPDPP4PDPK1GDALMNA
Water SCHEMBL9697811 0.78 PNP (0.47) PNPDPP4PDPK1GDAALDH1A1
Hydrochloric Acid SCHEMBL27339406 0.78 ATAD2 (0.51) PNPDPP4PDPK1GDALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119016735-A Gold nanocluster aggregate with multiple stimulus responsivity and preparation method and application thereof 中国科学院苏州纳米技术与纳米仿生研究所 2024-11-26 — — CN claimed
WO-2022160323-A1 APPLICATION OF NUCLEOSIDE ANALOGUE IN PREPARATION OF DRUGS FOR PREVENTING OR TREATING GASTROINTESTINAL DISEASES 兰州大学 2022-08-04 — — WO claimed
US-20220098262-A1 ANTIBODY-TUMOR NECROSIS FACTOR alpha FUSION PROTEIN AND ITS PREPARATION AND APPLICATIONS DING, Bang (CN) 2022-03-31 — — US claimed
WO-2020233723-A1 QUINOLINE DERIVATIVES FOR TREATMENT OF HEAD AND NECK CANCER 正大天晴药业集团股份有限公司 (CN) 2020-11-26 — — WO claimed
WO-2020118605-A1 ANTIBODY-TUMOR NECROSIS FACTOR-α FUSION PROTEIN, PREPARATION METHOD THEREFOR AND USES THEREOF 丁邦 2020-06-18 — — WO claimed
CN-109422652-A Application of the salicylic derivative of chloroethene acyloxy in drug 南京大学 2019-03-05 — — CN claimed
CN-104169421-A Oligonucleotides for modulating gene expression and uses thereof BIOGENERA SOCIETA A RESPONSABILITA LIMITATA 2014-11-26 — — CN claimed
CN-101642451-A New application of amiodarone and derivatives thereof SHANGHAI AMBROSIA PHARMACEUTIC 2010-02-10 — — CN claimed
CN-101406468-A Use of benzofuryl derivative and pharmaceutical composition containing the same SHANGHAI INST ORGANIC CHEM (CN) 2009-04-15 — — CN claimed
CN-101406473-A Use of dihydropyrimidine compound and pharmaceutical composition containing the same SHANGHAI INST ORGANIC CHEM (CN) 2009-04-15 — — CN claimed
CN-101406470-A Use of heterocyclic ring derivative of pyridine and pharmaceutical composition containing the same SHANGHAI INST ORGANIC CHEM (CN) 2009-04-15 — — CN claimed
EP-1583842-A4 METHODS FOR THE ELECTROCHEMICAL DETECTION OF MULTIPLE TARGET COMPOUNDS UNIV NORTH CAROLINA (US) 2007-07-04 — — EP claimed
EP-1583842-A2 METHODS FOR THE ELECTROCHEMICAL DETECTION OF MULTIPLE TARGET COMPOUNDS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2005-10-12 — — EP claimed
WO-2003089895-A2 METHODS FOR THE ELECTROCHEMICAL DETECTION OF MULTIPLE TARGET COMPOUNDS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2003-10-30 — — WO claimed
US-6638494-B1 Iron hydroxide, ferric hydrate, iron oxide, iron mixed oxide or iron; di- or polycarboxylic acid stabilizer; aggregation prevention; antitumor and contrast agents; immune boosters, magnetic resonance imaging, cell fusion, gene transfer PILGRIMM HERBERT (DE) 2003-10-28 — — US claimed
EP-0888545-B1 SUPER-PARAMAGNETIC PARTICLES WITH INCREASED R 1 RELAXIVITY, PROCESSES FOR PRODUCING SAID PARTICLES AND USE THEREOF PILGRIMM HERBERT (DE) 2002-01-23 — — EP claimed
US-6242428-B1 NUCLEOSIDES AND NUCLEOSIDE DIMERS CONTAINING AN L-SUGAR IN AT LEAST ONE OF THE NUCLEOSIDES UNISEARCH LIMITED (AU) 2001-06-05 — — US claimed
EP-1069903-A1 NOVEL NUCLEOSIDE ANALOGS AND USES IN TREATING DISEASE Lipitek International, Inc. (US) 2001-01-24 — — EP claimed
WO-1999045935-A1 NOVEL NUCLEOSIDE ANALOGS AND USES IN TREATING DISEASE LIPITEK INTERNATIONAL, INC. (US) 1999-09-16 — — WO claimed
EP-0689430-B1 SUPERPARAMAGNETIC PARTICLES, PROCESS FOR PRODUCING THE SAME AND THEIR USE SILICA GEL GMBH (DE) 1997-08-13 — — EP claimed
Send feedback